Enzyme Inhibitors Market Dynamics, Segments, Size and Demand, 2017 – 2027

Enzyme Inhibitors Market May 2017

About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client.

Research Capabilities    

Customized Research Syndicated Research Investment Research

Social Media Research

Customized Research Syndicated Research Investment Research Social Media Research

Sector Coverage    

Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment

   

Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

2

Research Methodology (1/2) Systematic Research Approach 1 Market profiling

2 Formulating discussion guide

3 Developing list of respondents

4

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts

Data collection

PMR conducts interviews with industry experts, industry players, distributors and retailers

Data validation

Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data

5 6

Data analysis

Insights

7

Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format (PDF)

Data Collection

   

Research & Intelligence

Data Filter & Analysis

Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain

Actionable Insights

A Primary Research

     

B SOLUTION     

Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments

Primary Research #    

Linkedin Zoominfo Salesforce Avention

Business Solution

Desk Research

C

Key industry experts Channel study Developments Market dynamics Products Conclusions

Company Analysis

Secondary Research #    

Company websites Company annual reports White papers Financial reports

Paid Publications#    

Factiva GBI Genios Meltwater

# includes sources of databases

3

Enzyme Inhibitors Market Enzyme inhibition means interruption or decrease in the enzyme activity. The enzyme inhibitors are substances that abolish or reduce the rate of enzyme action. Though enzymes are essential for life, abnormally high enzyme activity can lead to disease conditions. Hence, manipulation of enzyme catalysis with inhibitors is critical for prevention of infectious diseases, treatment of hypertension, control of inflammatory response, intervention in cell growth and cell cycle and much more. Also, besides acting as therapeutic agents, enzyme inhibitors play important roles in biological and clinical research. Enzyme Inhibitors Market: Drivers and Restraints The route of inhibitor administration is dependent on the properties and objective of the experiment to be carried out. Immobilized enzymes are used in industries and have a high value for industrial and medicinal enzyme products. Some of the examples of industrial enzymes are glucoamylase, amylase, pepsin, trypsin, glucose isomerase, cellulase and many others. With the emergence of new inhibitor enzymes in the quest for drug discovery, several new inhibition mechanisms are expected. Recently, several software programs have emerged to visualize custom visual interface to see curve fits in realtime, graph transforms, equations using kinetic data and these data tables are directly generated. The challenge is that most times, basic presumptions do not hold true in enzyme reactions and addition of new factors further complicate the calculation of reactor outcome. The outcomes of computer-based kinetic calculations are less realistic with more chances of

4

Enzyme Inhibitors Market variants. Another major challenge in the enzyme inhibitor market is that it is less reproducible and bioapplications are unpredictable because of synergy, the interplay of known and unknown physiological, biological, physical, and molecular factors affecting the reaction kinetics. Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3260 Enzyme Inhibitors Market: Segmentation On the basis of disease indication, the enzyme inhibitor market can be segmented into: Chronic Obstructive Pulmonary Disorders Cardiovascular Disease Gastrointestinal , Disorders Arthritis Inflammatory Diseases

5

Enzyme Inhibitors Market Arthritis Inflammatory Diseases Others The majority of drugs to treat a number of chronic and life-threatening diseases are developed with a mechanism of action directed towards enzyme inhibition. Enzyme specificity and potency are the important factors considered while developing a drug. A high specificity and potency ensure that a drug will have fewer side effects and a strong therapeutic effect. Enzyme inhibitors are used as diagnostic agents to screen various diseases thus propelling the growth of enzyme inhibitor market. Enzyme Inhibitors Market: Overview The emerging therapeutic market for enzyme inhibitors used in human therapeutics is very high. New information is available on biochemistry for enzyme inhibitors and classes of enzyme-inhibiting products with broad current or potential therapeutic applications in large markets. However, more than 90 enzyme inhibitors are currently marketed and double those are under development. A better understanding of the emerging enzyme inhibitors on enzyme mechanism is key. In recent years, use of chemical immobilization has extended

6

Enzyme Inhibitors Market

to immobilized antibodies or antigens in bio-affinity chromatography. In coming years, it is speculated that immobilization techniques of proteins and enzymes will have a greater impact on point-of-care medical and health business in the enzyme inhibitor market. Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3260 Enzyme Inhibitors Market: Region-wise Outlook On the basis of region, the market is segmented into North America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan, Latin America and the Middle East and Africa. The market for enzyme inhibitors is expanding with the rising incidence of enzyme-based diseases and increasing research and development activities. In developed countries like the U.S. and Europe, the market growth for enzyme inhibitors is high because of better availability of medical facilities, diagnosis rate for the diseases, infrastructure, awareness and available treatment options. In Asia Pacific region, China, Japan, and India are most potential markets for enzyme inhibitors due to growing population, improvement in medical facilities and economic development.

7

Enzyme Inhibitors Market Enzyme Inhibitors Market: Key Players Some of the players in the enzyme inhibitors market are AstraZeneca, Merck and Co. Inc., Novartis AG, Pfizer Inc., Ranbaxy Laboratories Ltd, Roche-Genentech Holding Ltd., and Takeda Pharmaceuticals. Other prominent players are Abbott Laboratories Inc., Bayer AG, and Johnson and Johnson Ltd. Vendors in this market are outsourcing different parts of their research work such as toxicology testing, product characterization testing to various contract research organizations. Also, vendors are increasingly engaged in outsourcing part of their enzyme inhibitor drug manufacturing or the entire manufacturing process to various contract manufacturing organizations. Thus, the increase in outsourcing of drug manufacturing is one of the trends witnessed in the enzyme inhibitors market.

8

To know more about us, please visit our website:

www.futuremarketinsights.com For sales queries or new topics email us on:

sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact:

Harish Tiwari (General Manager & Global Head Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

Thank You Future Market Insights Global & Consulting Private Limited (FMI)

9

Turn static files into dynamic content formats.

Create a flipbook